On August 31, 2026, DFZQ bought 30,800 shares of SKB BIO (06990) stock at an average of HKD 492.9088 per share, involving about HKD 15.18 million.
Prior to the acquisition, DFZQ's long position in SKB BIO was 8.84 million shares, representing 4.99%; following the acquisition, the holding changed to 8.87 million shares, with the long position ratio rising to 5.01%.